Bio-Techne CFO acquires 11,545 shares as awards vest
Separate option holdings include a 37,632-share tranche with a $53.60 exercise price expiring August 15, 2035.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Bio-Techne CFO James Hippel reported the conversion of 11,545 restricted stock units into 11,545 common shares on November 1, 2026. On the same date, 5,096 shares were delivered or withheld for payment of exercise price or tax liability. His reported direct holdings also include stock options and restricted stock units, with option expirations ranging from August 5, 2027, to August 15, 2035.
Insider Trade Summary
11,545 shares exercised/converted
Exercise
3 txns
Insider
Hippel James
Role
CFO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units F5, F9 | 11,545 | $0.00 | $0.00 |
| Exercise | Common Stock | 11,545 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 5,096 | $72.66 | $370K |
| Holding | Stock Options (Right to Buy) F1 | -- | -- | -- |
| Holding | Stock Options (Right to Buy) F1 | -- | -- | -- |
| Holding | Stock Options (Right to Buy) F1 | -- | -- | -- |
| Holding | Stock Options (Right to Buy) F1 | -- | -- | -- |
| Holding | Stock Options (Right to Buy) F2 | -- | -- | -- |
| Holding | Stock Options (Right to Buy) F3 | -- | -- | -- |
| Holding | Stock Options (Right to Buy) F4 | -- | -- | -- |
| Holding | Performance Restricted Stock Units F5, F6 | -- | -- | -- |
| Holding | Performance Restricted Stock Units F5, F7 | -- | -- | -- |
| Holding | Restricted Stock Units F5, F8 | -- | -- | -- |
| Holding | Restricted Stock Units F5, F10 | -- | -- | -- |
| Holding | Restricted Stock Units F5, F11 | -- | -- | -- |
| Holding | Restricted Stock Units F5, F12 | -- | -- | -- |
Holdings After Transaction:
Restricted Stock Units — 84,259 contracts for 72,715 underlying shares (Direct);
Common Stock — 176,720 shares (Direct);
Stock Options (Right to Buy) — 371,927 contracts (Direct);
Performance Restricted Stock Units — 53,482 contracts (Direct)
Footnotes (12)
- F1. Fully exercisable.
- F2. Options to purchase 11,481 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027, and options to purchase 11,480 shares vest on 8/15/2026.
- F3. Options to purchase 8,104 shares vest on each of 8/15/2025, 8/15/2026 and 8/15/2027, and options to purchase 8,105 shares vest on 8/15/2028.
- F4. Options to purchase 12,544 shares vest on each of 8/15/2026, 8/15/2027 and 8/15/2028.
- F5. Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock.
- F6. Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- F7. Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- F8. 4,011 restricted stock units vest on 8/15/2027.
- F9. 11,545 restricted stock units vest on 11/1/2026; and 11,544 restricted stock units vest on 11/1/2027.
- F10. 4,903 restricted stock units vest on 8/15/2027, and 4,904 restricted stock units vest on 8/15/2028.
- F11. 7,479 restricted stock units vest on each of 8/17/2027 and 8/17/2028, and 7,480 restricted stock units vest on 8/17/2029.
- F12. 36,459 restricted stock units vest on 8/17/2029.
Key Figures
Restricted stock units vested: 11,545 restricted stock units
Common shares acquired: 11,545 shares
Shares delivered or withheld: 5,096 shares
+2 more
5 metrics
Restricted stock units vested
11,545 restricted stock units
November 1, 2026
Common shares acquired
11,545 shares
November 1, 2026
Shares delivered or withheld
5,096 shares
Payment of exercise price or tax liability on November 1, 2026
Stock options to purchase common stock
167,328 underlying shares; $66.97 exercise price per share
Expire August 5, 2027
Stock options to purchase common stock
37,632 underlying shares; $53.60 exercise price per share
Expire August 15, 2035
Key Terms
restricted stock unit, Stock Options (Right to Buy), performance goals, contingent right
4 terms
restricted stock unit technical
"Each restricted stock unit represents a contingent right"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
Stock Options (Right to Buy) technical
"Stock Options (Right to Buy)"
performance goals technical
"if certain performance goals are achieved"
Performance goals are specific, measurable targets a company sets for financial results, operational milestones, or individual roles—examples include revenue, profit, production levels, or completion of a project. They matter to investors because meeting or missing these targets influences management pay, future forecasts, deal-related payments and market confidence; think of them as a scoreboard that helps outsiders judge whether the business is performing as promised.
contingent right technical
"represents a contingent right to receive one share"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stock options did TECH CFO James Hippel report?
The reported direct option holdings include 167,328 options at a $66.97 exercise price, expiring August 5, 2027; 40,536 at $120.46, expiring August 6, 2028; and 37,632 at $53.60, expiring August 15, 2035.
AI-generated analysis. How Rhea-AI works. Not financial advice.
